1Papaharalambus CA,Griendling KK.Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury[J].Trends Cardiovasc Med,2007,17(2):48-54.
3Armando R,Hector F,Lamberto R,et al.Oxidative stress at the vascular wall mechanistic and pharmacological aspects[J].Archives Medical Research,2006,(37):436-448.
4Steinberg D,Witztum JL.Is the oxidative modification hypothesis relevant to human atherosclerosis?Do the antioxidant trials conducted to date refute the hypothesis[J].Circulation,2002,105(17):2107-2111.
5Zohlnhfer D,Hausleiter J,Kastrati A,et al.A randomized,double-blind,placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib[J].J Am Coll Cardiol,2005,46(11):1999-2003.
6Joviliano EE,Piccinato CE,Dellalibera-Joviliano R,et al.Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting:current concepts[J].Ann Vasc Surg,2011,25(6):846-855.
10Jimi S,Saku K,Kusaba H,et al.Deposition of oxidized low-density lipoprotein and collagenosis occur coincidentally in human coronary stenosis:an immunohistochemical study of atherectomy[J].Coron Artery Dis,1998,9(9):551-557.
9Ross R. Atherosclerosis: an inflammatory disease[J]. N Engl J Med,1999,340(2):115 - 126.
10Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study)[J].Arterioscler Thromb Vasc Biol,2002,22(7) :1162 - 1167.
